Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 16-Sep-24
Select bar for recommendation details.
Recommendations | 16-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Ovid Therapeutics Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.30. The median estimate represents a 183.02% increase from the last price of 1.06.
High | 371.7% | 5.00 |
Med | 183.0% | 3.00 |
Low | 22.6% | 1.30 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 01, 2024.
Average growth rate | -1.22% |
Average growth rate | +6.82% |
More ▼
Revenue history & estimates in USD
Average growth rate | +23.51% |
Average growth rate | +459.47% |
More ▼